Katharine J. Bee

Chatillon-la-borde, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities.

Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: January 13, 2025

Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).

Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).

Journal: The journal of allergy and clinical immunology. In practice

Published: August 13, 2024

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.

Journal: The journal of allergy and clinical immunology. In practice

Published: August 07, 2024

Epicutaneous immunotherapy for the treatment of peanut allergy.

Epicutaneous immunotherapy for the treatment of peanut allergy.

Journal: Allergy

Published: April 16, 2024

Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.

Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.

Journal: JAMA pediatrics

Published: February 26, 2024

Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.

Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.

Journal: Expert review of clinical immunology

Published: February 07, 2024

Recent advances in epicutaneous immunotherapy and potential applications in food allergy.

Recent advances in epicutaneous immunotherapy and potential applications in food allergy.

Journal: Frontiers in allergy

Published: September 06, 2023

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.

Journal: The New England journal of medicine

Published: May 10, 2023

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities.

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities.

Journal: The journal of allergy and clinical immunology. Global

Published: March 10, 2022

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy.

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy.

Journal: Allergy

Published: September 07, 2021

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer.

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer.

Journal: International journal of molecular sciences

Published: May 24, 2021

An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.

An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.

Journal: Allergy and asthma proceedings

Published: June 17, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026